Concepedia

Author

Yann Seimbille

Erasmus MCORCID

Also Known As

Boulahdour, Hatem, Camporese, Davide, Didier J. Colin, H. Boulahdour, Seimbille, Y., Seimbille, Yann, Y. Seimbille, Yan Seimbille, Yann Seimbille

135

Publications

2.9K

Citations

23

H-Index

79

Concepts

All Affiliations

Erasmus MCUniversity Hospital of GenevaTRIUMFUniversity of GenevaErasmus University Rotterdam
YS

About

Yann Seimbille is an author at Erasmus MC specializing in medicine, positron emission tomography, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

1.6K

2

Health Sciences

5

5

585

3

Engineering

3

3

76

4

Natural Sciences

1

1

31

5

Public Health

1

1

30

Yann Seimbille

×

35

Publications

2.5K

Citations

20

H-Index

YearCitations

Gut Microbiota Orchestrates Energy Homeostasis during Cold

Claire Chevalier, Ozren Stojanović, Didier Colin,

Cell

2015

845

Microbiota depletion promotes browning of white adipose tissue and reduces obesity

Nicolas Suárez-Zamorano, Salvatore Fabbiano, Claire Chevalier,

Nature Medicine

2015

396

Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors

Helen C. Su, Claudia Bodenstein, Rebecca A. Dumont,

Clinical Cancer Research

2006

203

Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity

A. Quercioli, Zoltan Pataky, Gabriella Vincenti,

European Heart Journal

2011

148

Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors

Helen C. Su, Yann Seimbille, Gregory Z. Ferl,

European Journal of Nuclear Medicine and Molecular Imaging

2008

104

18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals

Yann Seimbille, Jacques Rousseau, François Bénard,

Steroids

2002

75

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality

Gert Luurtsema, Verena Pichler, Salvatore Bongarzone,

EJNMMI Radiopharmacy and Chemistry

2021

75

Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC

Eline Hooijman, Yozlem Chalashkan, Sui Wai Ling,

Pharmaceutics

2021

55

Fluorine‐18 labeling of 6,7‐disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of <sup>18</sup>F‐Iressa and related molecular probes

Yann Seimbille, Michael E. Phelps, Johannes Czernin,

Journal of Labelled Compounds and Radiopharmaceuticals

2005

48

First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy

Franz Buchegger, Valentina Garibotto, Thomas Zilli,

European Journal of Nuclear Medicine and Molecular Imaging

2013

48

Page 1